ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,382, issued on Feb. 4, was assigned to The General Hospital Corp. (Boston).

"Liver protective MARC variants and uses thereof" was invented by Sekar Kathiresan (Boston) and Connor Emdin (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are MARC variants that associate with a risk of liver diseases or a symptom(s) thereof, such as cirrhosis, or protection against such liver diseases or symptom(s) thereof. Also described herein are compositions and formulations that can be capable of modulating MARC in a subject and/or treatment of a liver disease or a symptom thereof."

The patent was filed on March 2, 2020, under Application No. ...